Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tolerability and patient/physician satisfaction with subcutaneously administered methotrexate provided in two formulations of different drug concentrations in patients with rheumatoid arthritis.
Müller-Ladner U, Rockwitz K, Brandt-Jürgens J, Haux R, Kästner P, Braun J, Demary W, Guimbal-Schmolck C, Pichlmeier U, Brandt A; MC-MTX.10/RH Study Group. Müller-Ladner U, et al. Among authors: demary w. Open Rheumatol J. 2010 Mar 18;4:15-22. doi: 10.2174/1874312901004010015. Open Rheumatol J. 2010. PMID: 20461222 Free PMC article.
Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.
Demary W, Schwenke H, Rockwitz K, Kästner P, Liebhaber A, Schoo U, Hübner G, Pichlmeier U, Guimbal-Schmolck C, Müller-Ladner U. Demary W, et al. Patient Prefer Adherence. 2014 Aug 6;8:1061-71. doi: 10.2147/PPA.S64111. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 25125973 Free PMC article.
Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
Braun J, Kästner P, Flaxenberg P, Währisch J, Hanke P, Demary W, von Hinüber U, Rockwitz K, Heitz W, Pichlmeier U, Guimbal-Schmolck C, Brandt A; MC-MTX.6/RH Study Group. Braun J, et al. Among authors: demary w. Arthritis Rheum. 2008 Jan;58(1):73-81. doi: 10.1002/art.23144. Arthritis Rheum. 2008. PMID: 18163521 Free article. Clinical Trial.
Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs.
Strangfeld A, Richter A, Siegmund B, Herzer P, Rockwitz K, Demary W, Aringer M, Meißner Y, Zink A, Listing J. Strangfeld A, et al. Among authors: demary w. Ann Rheum Dis. 2017 Mar;76(3):504-510. doi: 10.1136/annrheumdis-2016-209773. Epub 2016 Jul 12. Ann Rheum Dis. 2017. PMID: 27405509 Free PMC article.
[Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists].
Heberlein I, Demary W, Bloching H, Braun J, Buttgereit F, Dreher R, Kuhn C, Lange U, Zink A, Zeidler H, Häntzschel H, Raspe H. Heberlein I, et al. Among authors: demary w. Z Rheumatol. 2011 Sep;70(7):592-601. doi: 10.1007/s00393-011-0821-7. Z Rheumatol. 2011. PMID: 21755301 German.
Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.
Gerhold K, Richter A, Schneider M, Bergerhausen HJ, Demary W, Liebhaber A, Listing J, Zink A, Strangfeld A. Gerhold K, et al. Among authors: demary w. Rheumatology (Oxford). 2015 Oct;54(10):1858-66. doi: 10.1093/rheumatology/kev194. Epub 2015 May 21. Rheumatology (Oxford). 2015. PMID: 26001633 Free PMC article.
20 results